Literature DB >> 6849025

Patients' perceptions of the cosmetic impact of melanoma resection.

B R Cassileth, E J Lusk, A N Tenaglia.   

Abstract

This study investigated the relationship between primary versus grafted closure for melanoma and the cosmetic impact on the patient of the resulting scar. A total of 176 patients with melanoma completed a multiple-choice questionnaire designed for this study. Two factors were significantly related to negative cosmetic impact: severity of scar indentation (but not scar length) and the extent to which patients were unprepared for the actual size of their scars. Patients whose scars were deeply indented as well as those whose scars were larger than anticipated displayed greatest distress about their appearance. Cosmetic impact was greater for women than for men. These observations suggest that primary closures, rather than closures requiring skin grafts, have important psychological benefits for patients and that physicians can assist postoperative adjustment by giving patients accurate information about the expected appearance of their scars.

Entities:  

Mesh:

Year:  1983        PMID: 6849025     DOI: 10.1097/00006534-198301000-00016

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  15 in total

Review 1.  Psychological interventions for cancer patients to enhance the quality of life.

Authors:  B L Andersen
Journal:  J Consult Clin Psychol       Date:  1992-08

2.  FACE-Q Skin Cancer Module for measuring patient-reported outcomes following facial skin cancer surgery.

Authors:  E H Lee; A F Klassen; S J Cano; K S Nehal; A L Pusic
Journal:  Br J Dermatol       Date:  2018-05-23       Impact factor: 9.302

Review 3.  Talimogene Laherparepvec for Treating Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Authors:  Nigel Fleeman; Adrian Bagust; Angela Boland; Sophie Beale; Marty Richardson; Ashma Krishan; Angela Stainthorpe; Ahmed Abdulla; Eleanor Kotas; Lindsay Banks; Miranda Payne
Journal:  Pharmacoeconomics       Date:  2017-10       Impact factor: 4.981

4.  Creation of a quality of life instrument for nonmelanoma skin cancer patients.

Authors:  John S Rhee; B Alex Matthews; Marcy Neuburg; Mary Burzynski; Ann B Nattinger
Journal:  Laryngoscope       Date:  2005-07       Impact factor: 3.325

5.  Scarring, disfigurement, and quality of life in long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor study.

Authors:  Karen E Kinahan; Lisa K Sharp; Kristy Seidel; Wendy Leisenring; Aarati Didwania; Mario E Lacouture; Marilyn Stovall; Anand Haryani; Leslie L Robison; Kevin R Krull
Journal:  J Clin Oncol       Date:  2012-05-21       Impact factor: 44.544

Review 6.  Assessment of patient-reported outcomes in patients with melanoma.

Authors:  Janice N Cormier; Robert L Askew
Journal:  Surg Oncol Clin N Am       Date:  2011-01       Impact factor: 3.495

7.  Is surviving enough? Coping and impact on activities of daily living among melanoma patients with lymphoedema.

Authors:  K D Cromwell; Y J Chiang; J Armer; P P Heppner; K Mungovan; M I Ross; J E Gershenwald; J E Lee; R E Royal; A Lucci; J N Cormier
Journal:  Eur J Cancer Care (Engl)       Date:  2015-03-24       Impact factor: 2.520

8.  [Psychosocial counseling of skin cancer patients in these times of diagnosis related groups (DRG)].

Authors:  G Strittmatter
Journal:  Hautarzt       Date:  2004-08       Impact factor: 0.751

9.  Multidimensional analysis of body image concerns among newly diagnosed patients with oral cavity cancer.

Authors:  Michelle Cororve Fingeret; Damon J Vidrine; Gregory P Reece; Ann M Gillenwater; Ellen R Gritz
Journal:  Head Neck       Date:  2010-03       Impact factor: 3.147

10.  The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma.

Authors:  J W Kelly; R W Sagebiel; W Calderon; L Murillo; R L Dakin; M S Blois
Journal:  Ann Surg       Date:  1984-12       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.